Interpreting Key Trials
Alpha-blockers and congestive heart failure: Early termination of an arm of the ALLHAT trial
Donald G. Vidt, MD
Cleveland Clinic Journal of Medicine June 2000, 67 (6) 429-433;
Donald G. Vidt
Consultant, Department of Nephrology and Hypertension, Cleveland Clinic; member, Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; investigator, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Article Information
vol. 67 no. 6 429-433
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online June 1, 2000.
Copyright & Usage
Copyright © 2000 The Cleveland Clinic Foundation. All Rights Reserved.
Cited By...
In this issue
Cleveland Clinic Journal of Medicine
Vol. 67, Issue 6
1 Jun 2000
Alpha-blockers and congestive heart failure: Early termination of an arm of the ALLHAT trial
Donald G. Vidt
Cleveland Clinic Journal of Medicine Jun 2000, 67 (6) 429-433;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Mortality and Morbidity During and After Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: Results by Sex
- Diuretic Versus {alpha}-Blocker as First-Step Antihypertensive Therapy: Final Results From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)





